This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scudiero, D. A. Articles by Boyd, M. R. Search for Related Content PubMed PubMed Citation Articles by Scudiero, D. A. Articles by Boyd, M. R.

Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines¹

Program Resources, Inc., National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland 21701 [D. A. S., A. M., S. T., M. C., T. N., D. S.], and Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892 [R. S., K. P., M. B.]

We have previously described the application of an automated microculture tetrazolium assay (MTA) involving dimethyl sulfoxide solubilization of cellular-generated 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-formazan to the in vitro assessment of drug effects on cell growth (M. C. Alley et al., Proc. Am. Assoc. Cancer Res., 27:389, 1986; M. C. Alley et al., Cancer Res. 48: 589–601, 1988). There are several inherent disadvantages of this assay, including the safety hazard of personnel exposure to large quantities of dimethyl sulfoxide, the deleterious effects of this solvent on laboratory equipment, and the inefficient metabolism of MTT by some human cell lines. Recognition of these limitations prompted development of possible alternative MTAs utilizing a different tetrazolium reagent, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT), which is metabolically reduced in viable cells to a water-soluble formazan product. This reagent allows direct absorbance readings, therefore eliminating a solubilization step and shortening the microculture growth assay procedure. Most human tumor cell lines examined metabolized XTT less efficiently than MTT; however, the addition of phenazine methosulfate (PMS) markedly enhanced cellular reduction of XTT. In the presence of PMS, the XTT reagent yielded usable absorbance values for growth and drug sensitivity evaluations with a variety of cell lines. Depending on the metabolic reductive capacity of a given cell line, the optimal conditions for a 4-h XTT incubation assay were 50 µg of XTT and 0.15 to 0.4 µg of PMS per well. Drug profiles obtained with representative human tumor cell lines for several standard compounds utilizing the XTT-PMS methodology were similar to the profiles obtained with MTT. Addition of PMS appeared to have little effect on the metabolism of MTT. The new XTT reagent thus provides for a simplified, in vitro cell growth assay with possible applicability to a variety of problems in cellular pharmacology and biology. However, the MTA using the XTT reagent still shares many of the limitations and potential pitfalls of MTT or other tetrazolium-based assays.

¹ Supported by NCI Contract N01-CO-23910 with Program Resources, Inc.

² To whom requests for reprints should be addressed, at Building 539, National Cancer Institute-Frederick Cancer Research Facility, Frederick, MD 21701.

Received 7/10/87. Revised 1/ 6/88. Accepted 5/17/88.

This article has been cited by other articles:

				W. Zhang and L.-Y. Lim Effects of Spice Constituents on P-Glycoprotein-Mediated Transport and CYP3A4-Mediated Metabolism in Vitro Drug Metab. Dispos., July 1, 2008; 36(7): 1283 - 1290. [Abstract] [Full Text] [PDF]

				J. D. Stallings, Y. X. Zeng, F. Narvaez, and M. J. Rebecchi Phospholipase C-{delta}1 Expression Is Linked to Proliferation, DNA Synthesis, and Cyclin E Levels J. Biol. Chem., May 16, 2008; 283(20): 13992 - 14001. [Abstract] [Full Text] [PDF]

				H. Ammar and J. L. Closset Clusterin Activates Survival through the Phosphatidylinositol 3-Kinase/Akt Pathway J. Biol. Chem., May 9, 2008; 283(19): 12851 - 12861. [Abstract] [Full Text] [PDF]

				S. L. Binford, P. T. Weady, F. Maldonado, M. A. Brothers, D. A. Matthews, and A. K. Patick In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C Protease Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4366 - 4373. [Abstract] [Full Text] [PDF]

				J. R. Ridpath, A. Nakamura, K. Tano, A. M. Luke, E. Sonoda, H. Arakawa, J.-M. Buerstedde, D. A.F. Gillespie, J. E. Sale, M. Yamazoe, et al. Cells Deficient in the FANC/BRCA Pathway Are Hypersensitive to Plasma Levels of Formaldehyde Cancer Res., December 1, 2007; 67(23): 11117 - 11122. [Abstract] [Full Text] [PDF]

				C. J. Henrich, R. W. Robey, H. R. Bokesch, S. E. Bates, S. Shukla, S. V. Ambudkar, M. Dean, and J. B. McMahon New inhibitors of ABCG2 identified by high-throughput screening Mol. Cancer Ther., December 1, 2007; 6(12): 3271 - 3278. [Abstract] [Full Text] [PDF]

				C.-C. Hou, Y.-P. Chen, J.-H. Wu, C.-C. Huang, S.-Y. Wang, N.-S. Yang, and L.-F. Shyur A Galactolipid Possesses Novel Cancer Chemopreventive Effects by Suppressing Inflammatory Mediators and Mouse B16 Melanoma Cancer Res., July 15, 2007; 67(14): 6907 - 6915. [Abstract] [Full Text] [PDF]

				W. Boehmerle, K. Zhang, M. Sivula, F. M. Heidrich, Y. Lee, S.-E. Jordt, and B. E. Ehrlich Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation PNAS, June 26, 2007; 104(26): 11103 - 11108. [Abstract] [Full Text] [PDF]

				K. M. Ruocco, E. I. Goncharova, M. R. Young, N. H. Colburn, J. B. McMahon, and C. J. Henrich A High-Throughput Cell-Based Assay to Identify Specific Inhibitors of Transcription Factor AP-1 J Biomol Screen, February 1, 2007; 12(1): 133 - 139. [Abstract] [PDF]

				M. Schmitz, A. Becker, A. Schmitz, C. Weirich, M. Paulsson, F. Zaucke, and R. Dinser Disruption of Extracellular Matrix Structure May Cause Pseudoachondroplasia Phenotypes in the Absence of Impaired Cartilage Oligomeric Matrix Protein Secretion J. Biol. Chem., October 27, 2006; 281(43): 32587 - 32595. [Abstract] [Full Text] [PDF]

				M. A. Hussain, D. L. Porras, M. H. Rowe, J. R. West, W.-J. Song, W. E. Schreiber, and F. E. Wondisford Increased Pancreatic {beta}-Cell Proliferation Mediated by CREB Binding Protein Gene Activation Mol. Cell. Biol., October 15, 2006; 26(20): 7747 - 7759. [Abstract] [Full Text] [PDF]

				S. A. B. Knight and A. Dancis Reduction of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) is dependent on CaFRE10 ferric reductase for Candida albicans grown in unbuffered media. Microbiology, August 1, 2006; 152(Pt 8): 2301 - 2308. [Abstract] [Full Text] [PDF]

				C. J. Henrich, H. R. Bokesch, M. Dean, S. E. Bates, R. W. Robey, E. I. Goncharova, J. A. Wilson, and J. B. McMahon A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity J Biomol Screen, March 1, 2006; 11(2): 176 - 183. [Abstract] [PDF]

				J. Nakayama, Y. Ogawa, Y. Yoshigae, Y. Onozawa, A. Yonemura, M. Saito, K. Ichikawa, T. Yamoto, T. Komai, T. Tatsuta, et al. A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells Int. Immunol., January 1, 2006; 18(1): 113 - 124. [Abstract] [Full Text] [PDF]

				R. Gilmour, J. E. Foster, Q. Sheng, J. R. McClain, A. Riley, P.-M. Sun, W.-L. Ng, D. Yan, T. I. Nicas, K. Henry, et al. New Class of Competitive Inhibitor of Bacterial Histidine Kinases J. Bacteriol., December 1, 2005; 187(23): 8196 - 8200. [Abstract] [Full Text] [PDF]

				T.-C. Chou, H. Dong, X. Zhang, W. P. Tong, and S. J. Danishefsky Therapeutic Cure against Human Tumor Xenografts in Nude Mice by a Microtubule Stabilization Agent, Fludelone, via Parenteral or Oral Route Cancer Res., October 15, 2005; 65(20): 9445 - 9454. [Abstract] [Full Text] [PDF]

				M. Biscardi, R. Caporale, F. Balestri, S. Gavazzi, J. Jimeno, and A. Grossi VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia Ann. Onc., October 1, 2005; 16(10): 1667 - 1674. [Abstract] [Full Text] [PDF]

				U. B. Mayr, C. Haller, W. Haidinger, A. Atrasheuskaya, E. Bukin, W. Lubitz, and G. Ignatyev Bacterial Ghosts as an Oral Vaccine: a Single Dose of Escherichia coli O157:H7 Bacterial Ghosts Protects Mice against Lethal Challenge Infect. Immun., August 1, 2005; 73(8): 4810 - 4817. [Abstract] [Full Text] [PDF]

				E. K. Nakakura, V. R. Sriuranpong, M. Kunnimalaiyaan, E. C. Hsiao, K. E. Schuebel, M. W. Borges, N. Jin, B. J. Collins, B. D. Nelkin, H. Chen, et al. Regulation of Neuroendocrine Differentiation in Gastrointestinal Carcinoid Tumor Cells by Notch Signaling J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4350 - 4356. [Abstract] [Full Text] [PDF]

				T. Takahashi, F. Yamasaki, T. Sudo, H. Itamochi, S. Adachi, M. Tamamori-Adachi, and N. T. Ueno Cyclin A-associated kinase activity is needed for paclitaxel sensitivity Mol. Cancer Ther., July 1, 2005; 4(7): 1039 - 1046. [Abstract] [Full Text] [PDF]

				A. K. Patick, M. A. Brothers, F. Maldonado, S. Binford, O. Maldonado, S. Fuhrman, A. Petersen, G. J. Smith III, L. S. Zalman, L. A. Burns-Naas, et al. In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2267 - 2275. [Abstract] [Full Text] [PDF]

				Y. XU, M. A. LEO, and C. S. LIEBER DLPC ATTENUATES ALCOHOL-INDUCED CYTOTOXICITY IN HEPG2 CELLS EXPRESSING CYP2E1 Alcohol Alcohol., May 1, 2005; 40(3): 172 - 175. [Abstract] [Full Text] [PDF]

				W. M. Spees, T. P.F. Gade, G. Yang, W. P. Tong, W. G. Bornmann, R. Gorlick, and J. A. Koutcher An 19F Magnetic Resonance-Based In Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle Clin. Cancer Res., February 15, 2005; 11(4): 1454 - 1461. [Abstract] [Full Text] [PDF]

				S. L. Binford, F. Maldonado, M. A. Brothers, P. T. Weady, L. S. Zalman, J. W. Meador III, D. A. Matthews, and A. K. Patick Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor Antimicrob. Agents Chemother., February 1, 2005; 49(2): 619 - 626. [Abstract] [Full Text] [PDF]

				A. R. Jazirehi, S. Huerta-Yepez, G. Cheng, and B. Bonavida Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-{kappa}B Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis Cancer Res., January 1, 2005; 65(1): 264 - 276. [Abstract] [Full Text] [PDF]

				G. J. Griffiths, M. Y. Koh, V. G. Brunton, C. Cawthorne, N. A. Reeves, M. Greaves, M. J. Tilby, D. G. Pearson, C. J. Ottley, P. Workman, et al. Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis J. Biol. Chem., October 29, 2004; 279(44): 46113 - 46121. [Abstract] [Full Text] [PDF]

				J.-i. Kashiwakura, H. Yokoi, H. Saito, and Y. Okayama T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast Cells J. Immunol., October 15, 2004; 173(8): 5247 - 5257. [Abstract] [Full Text] [PDF]

				A. R. Jazirehi, M. I. Vega, D. Chatterjee, L. Goodglick, and B. Bonavida Inhibition of the Raf-MEK1/2-ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin's Lymphoma B Cells by Rituximab Cancer Res., October 1, 2004; 64(19): 7117 - 7126. [Abstract] [Full Text] [PDF]

				G.-C. Huang, S.-Y. Liu, M.-H. Lin, Y.-Y. Kuo, and Y.-C. Liu The Synergistic Cytotoxicity of Cisplatin and Taxol in Killing Oral Squamous Cell Carcinoma Jpn. J. Clin. Oncol., September 1, 2004; 34(9): 499 - 504. [Abstract] [Full Text] [PDF]

				P. G. Magro, A. J. Russo, W.-W. Li, D. Banerjee, and J. R. Bertino p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53 Cancer Res., June 15, 2004; 64(12): 4338 - 4345. [Abstract] [Full Text] [PDF]

				W. E. G. Muller, V. A. Grebenjuk, N. L. Thakur, A. N. Thakur, R. Batel, A. Krasko, I. M. Muller, and H. J. Breter Oxygen-Controlled Bacterial Growth in the Sponge Suberites domuncula: toward a Molecular Understanding of the Symbiotic Relationships between Sponge and Bacteria Appl. Envir. Microbiol., April 1, 2004; 70(4): 2332 - 2341. [Abstract] [Full Text] [PDF]

				F. Piccioni, B. R. Roman, K. H. Fischbeck, and J. P. Taylor A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor Hum. Mol. Genet., February 15, 2004; 13(4): 437 - 446. [Abstract] [Full Text] [PDF]

				Z. A. Khan, M. Cukiernik, J. R. Gonder, and S. Chakrabarti Oncofetal Fibronectin in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 287 - 295. [Abstract] [Full Text] [PDF]

				A. S. RAIT, K. F. PIROLLO, D. ULICK, K. CULLEN, and E. H. CHANG HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 78 - 89. [Abstract] [Full Text] [PDF]

				Y. Okubo, K. Siddle, H. Firth, S. O'Rahilly, L. C. Wilson, L. Willatt, T. Fukushima, S.-I. Takahashi, C. J. Petry, T. Saukkonen, et al. Cell Proliferation Activities on Skin Fibroblasts from a Short Child with Absence of One Copy of the Type 1 Insulin-Like Growth Factor Receptor (IGF1R) Gene and a Tall Child with Three Copies of the IGF1R Gene J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5981 - 5988. [Abstract] [Full Text] [PDF]

				J. H. Davies, B. A. J. Evans, M. E. M. Jenney, and J. W. Gregory Effects of Chemotherapeutic Agents on the Function of Primary Human Osteoblast-Like Cells Derived from Children J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6088 - 6097. [Abstract] [Full Text] [PDF]

				K. Tanaka, T. Yamamoto, Y. Aikawa, K. Kizawa, K. Muramoto, H. Matsuno, and A. Muraguchi Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice Rheumatology, November 1, 2003; 42(11): 1365 - 1371. [Abstract] [Full Text] [PDF]

				W. M. Spees, G. Yang, D. Veach, M. B. Rubio, J. A. Koutcher, and W. Bornmann A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectra Mol. Cancer Ther., October 1, 2003; 2(10): 933 - 939. [Abstract] [Full Text]

				U. Schroeder, K. M. Bernt, B. Lange, J. Wenkel, J. Jikai, D. Shabat, R. Amir, N. Huebener, A. G. Niethammer, C. Hagemeier, et al. Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia Blood, July 1, 2003; 102(1): 246 - 253. [Abstract] [Full Text] [PDF]

				C. Mamot, D. C. Drummond, U. Greiser, K. Hong, D. B. Kirpotin, J. D. Marks, and J. W. Park Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells Cancer Res., June 15, 2003; 63(12): 3154 - 3161. [Abstract] [Full Text] [PDF]

				P. Ofek, D. Ben-Meir, Z. Kariv-Inbal, M. Oren, and S. Lavi Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Calpha J. Biol. Chem., April 11, 2003; 278(16): 14299 - 14305. [Abstract] [Full Text] [PDF]

				S. Chen, S. Mukherjee, C. Chakraborty, and S. Chakrabarti High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1 Am J Physiol Cell Physiol, February 1, 2003; 284(2): C263 - C272. [Abstract] [Full Text] [PDF]

				S. Alas and B. Bonavida Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis Clin. Cancer Res., January 1, 2003; 9(1): 316 - 326. [Abstract] [Full Text] [PDF]

				R. Szabo, G. Mezo, F. Hudecz, and L. Kohidai Effect of the Polylysine Based Polymeric Polypeptides on the Growth and Chemotaxis of Tetrahymena Pyriformis Journal of Bioactive and Compatible Polymers, November 1, 2002; 17(6): 399 - 415. [Abstract] [PDF]

				E.-Y. Moon and A. Lerner Benzylamide Sulindac Analogues Induce Changes in Cell Shape, Loss of Microtubules and G2-M Arrest in a Chronic Lymphocytic Leukemia (CLL) Cell Line and Apoptosis in Primary CLL Cells Cancer Res., October 15, 2002; 62(20): 5711 - 5719. [Abstract] [Full Text] [PDF]

				S. Huerta, J. R. Arteaga, R. W. Irwin, T. Ikezoe, D. Heber, and H. P. Koeffler PC-SPES Inhibits Colon Cancer Growth in Vitro and in Vivo Cancer Res., September 15, 2002; 62(18): 5204 - 5209. [Abstract] [Full Text] [PDF]

				B. B. Bordier, P. L. Marion, K. Ohashi, M. A. Kay, H. B. Greenberg, J. L. Casey, and J. S. Glenn A Prenylation Inhibitor Prevents Production of Infectious Hepatitis Delta Virus Particles J. Virol., September 11, 2002; 76(20): 10465 - 10472. [Abstract] [Full Text] [PDF]

				W. P. Revill, J. Voda, C. R. Reeves, L. Chung, A. Schirmer, G. Ashley, J. R. Carney, M. Fardis, C. W. Carreras, Y. Zhou, et al. Genetically Engineered Analogs of Ascomycin for Nerve Regeneration J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1278 - 1285. [Abstract] [Full Text] [PDF]

				T. Beckers, T. Reissmann, M. Schmidt, A. M. Burger, H. H. Fiebig, U. Vanhoefer, H. Pongratz, H. Hufsky, J. Hockemeyer, M. Frieser, et al. 2-Aroylindoles, a Novel Class of Potent, Orally Active Small Molecule Tubulin Inhibitors Cancer Res., June 1, 2002; 62(11): 3113 - 3119. [Abstract] [Full Text] [PDF]

				Y. Furuta, K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama, K. Kozaki, N. Nomura, H. Egawa, S. Minami, Y. Watanabe, et al. In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705 Antimicrob. Agents Chemother., April 1, 2002; 46(4): 977 - 981. [Abstract] [Full Text] [PDF]

				P. Chaturvedi, V. Sudakin, M. L. Bobiak, P. W. Fisher, M. R. Mattern, S. A. Jablonski, M. R. Hurle, Y. Zhu, T. J. Yen, and B.-B. S. Zhou Chfr Regulates a Mitotic Stress Pathway through its RING-Finger Domain with Ubiquitin Ligase Activity Cancer Res., March 1, 2002; 62(6): 1797 - 1801. [Abstract] [Full Text] [PDF]

				L E Kernochan, B N Tran, P Tangkijvanich, A C Melton, S P Tam, and H F Yee Jr Endothelin-1 stimulates human colonic myofibroblast contraction and migration Gut, January 1, 2002; 50(1): 65 - 70. [Abstract] [Full Text] [PDF]

				J. Meletiadis, J. W. Mouton, J. F. G. M. Meis, B. A. Bouman, P. J. Donnelly, P. E. Verweij, and EUROFUNG Network Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antifungal Susceptibility Testing of Aspergillus Species J. Clin. Microbiol., December 1, 2001; 39(12): 4256 - 4263. [Abstract] [Full Text] [PDF]

				E. Boonacker and C. J.F. Van Noorden Enzyme Cytochemical Techniques for Metabolic Mapping in Living Cells, with Special Reference to Proteolysis J. Histochem. Cytochem., December 1, 2001; 49(12): 1473 - 1486. [Abstract] [Full Text] [PDF]

				A. R. Jazirehi, C.-P. Ng, X.-H. Gan, G. Schiller, and B. Bonavida Adriamycin Sensitizes the Adriamycin-resistant 8226/Dox40 Human Multiple Myeloma Cells to Apo2L/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated (TRAIL) Apoptosis Clin. Cancer Res., December 1, 2001; 7(12): 3874 - 3883. [Abstract] [Full Text] [PDF]

				J. Meletiadis, J. W. Mouton, J. F. G. M. Meis, B. A. Bouman, J. P. Donnelly, P. E. Verweij, and EUROFUNG Network Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus Species J. Clin. Microbiol., September 1, 2001; 39(9): 3402 - 3408. [Abstract] [Full Text] [PDF]

				C. Nicot, J. C. Mulloy, M. G. Ferrari, J. M. Johnson, K. Fu, R. Fukumoto, R. Trovato, J. Fullen, W. J. Leonard, and G. Franchini HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells Blood, August 1, 2001; 98(3): 823 - 829. [Abstract] [Full Text] [PDF]

				R. Ni, M. A. Leo, J. Zhao, and C. S. Lieber Toxicity of {beta}-carotene and its exacerbation by acetaldehyde in HepG2 cells Alcohol Alcohol., July 1, 2001; 36(4): 281 - 285. [Abstract] [Full Text] [PDF]

S. Alas and B. Bonavida Rituximab Inactivates Signal Transducer and Activation of Transcription 3 (STAT3) Activity in B-Non-Hodgkin's Lymphoma through Inhibition of the Interleukin 10 Auto